Putting Function Back in Dysfunction: Endothelial Diseases and Current Therapies in Hematopoietic Stem Cell Transplantation and Cellular Therapies

0
38
Scientists summarize the current knowledge about statins and other agents used as endothelial protectants. They propose further studies using statins for prophylaxis and prevention of end-organ damage related to extensive endothelial dysfunction in hematopoietic stem cell transplantation and chimeric antigen receptor-T cells.
[Blood Reviews]
Sumransub, N., El Jurdi, N., Chiraphapphaiboon, W., & Maakaron, J. E. (2021). Putting function back in dysfunction: Endothelial diseases and current therapies in hematopoietic stem cell transplantation and cellular therapies. Blood Reviews, 100883. https://doi.org/10.1016/j.blre.2021.100883 Cite
Abstract